Pricing Log in Create free account

Pluri Inc. (PLUR) vs Vaxxinity, Inc. (VAXX)

Pluri Inc. and Vaxxinity, Inc. are both Biotechnology companies. Pluri Inc. and Vaxxinity, Inc. are of similar size ($15.5M and $15.0M). Vaxxinity, Inc. has the higher net margin (0.00% vs −2,344.6%) and the higher return on invested capital (0.00% vs −526.9%). Across the 14 metrics below, Vaxxinity, Inc. leads on 8 and Pluri Inc. on 6.

Valuation

Metric PLUR VAXX Biotechnology median
P/E n/m n/m 10.60
P/S 11.89 n/m 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.30 0.66
EV/Sales 31.96 (94.20) 9.02
Earnings yield (197.58%) 0.00% (32.88%)
Free cash flow yield (167.21%) 0.00% (23.13%)

Profitability

Metric PLUR VAXX Biotechnology median
Gross margin 44.59% 0.00% 68.51%
Operating margin (2,454.53%) 0.00% 0.00%
Net margin (2,344.59%) 0.00% 0.00%
Free cash flow margin (1,988.48%) 0.00% 0.00%
Return on equity 260.35% (150.65%) (51.96%)
Return on assets (74.95%) (75.55%) (46.06%)
Return on invested capital (526.92%) 0.00% 0.00%

Growth

Metric PLUR VAXX Biotechnology median
Revenue growth (TTM) (23.95%) — 6.76%
EPS growth (last fiscal year) 31.46% 25.00% 29.88%
Revenue growth, 5-year CAGR 113.32% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric PLUR VAXX Biotechnology median
Debt to equity (1.62) 0.99 0.00
Current ratio 0.27 1.89 4.97
Net debt to EBITDA (0.83) 0.30 1.01

Dividend

Metric PLUR VAXX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PLUR VAXX Biotechnology median
Market cap 15.00m 15.47m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack